1-3 of 3
Jenny L Craigen, PhD
Close
Sort by
Journal Articles

Evaluation Of Bcma As a Therapeutic Target In Multiple Myeloma Using An Antibody-Drug Conjugate

Kwee L Yong, PhD, Fiona M Germaschewski, BSc, Manuel Rodriguez-Justo, PhD, Danton Bounds, BSc, Lydia Lee, MD, Patrick A Mayes, PhD, Katherine Sully, PhD, Laura M Seestaller-Wehr, MS, William E Fieles, MS, James R Tunstead, PhD, Lee McCahon, Jennifer Paterson, BSc, Gaelle Herledan, BSc, Jenny L Craigen, PhD
Journal: Blood
Blood (2013) 122 (21): 4447.
https://doi.org/10.1182/blood.V122.21.4447.4447
Published: 2013
Journal Articles

Novel Fc-Engineered Anti-B Cell Maturation Antigen-Monomethyl Auristatin F Antibody-Drug Conjugate (GSK2857916) Induces Potent and Selective Anti-Multiple Myeloma Activity Via Enhanced Effector Function and Direct Tumor Cell Killing

Yu-Tzu Tai, PhD, Chirag Acharya, Mike Y Zhong, Michele Cea, MD, Antonia Cagnetta, MD, Patrick A Mayes, PhD, Jenny L Craigen, PhD, Louise Gliddon, James Smothers, Amanda L Christie, B.S., Andrew L. Kung, MD, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 877.
https://doi.org/10.1182/blood.V122.21.877.877
Published: 2013
Journal Articles

Ofatumumab, a Human Mab Targeting a Membrane-Proximal Small-Loop Epitope On CD20, Induces Potent NK Cell-Mediated ADCC.

Jenny L Craigen, PhD, Wendy J.M. Mackus, PhD, Patrick Engleberts, Sam R Miller, Sue Speller, Louise C Chamberlain, Bill G Davis, PhD, Simon M McHugh, PhD, Ed Bullmore, PhD, Charles J Cox, PhD, Sally Wetten, Gerrard Perdock, Joost M Bakker, PhD, Jan G. J. van de Winkel, PhD, Paul W. H. I. Parren, PhD
Journal: Blood
Blood (2009) 114 (22): 1725.
https://doi.org/10.1182/blood.V114.22.1725.1725
Published: 2009